Sex differences in toxicity and outcomes in patients with sarcoma.

Ilaria Tortorelli(Istituto Oncologico Veneto), Marina Coppola(Istituto Oncologico Veneto), Antonella Brunello(Istituto Oncologico Veneto)

Zenodo (CERN European Organization for Nuclear Research)

February 3, 2026

10.5281/zenodo.18467301

Cited by 0

Related Papers

Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment

|Critical Reviews in Oncology/Hematology|2024|11

Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World Setting

|Cancers|2023|5

Trabectedin and Radiation Therapy for Cardiac Metastasis From Leiomyosarcoma: A Case Report and Review of the Literature

|Frontiers in Oncology|2022|3

MDM2 inhibitors in sarcomas: results and next steps

|Current Opinion in Oncology|2025|2

Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer center

|Frontiers in Oncology|2025|1